Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension

Journal of Hypertension

Volumn 30, Issue 8, 2012, Pages 1665-1670

  Alnima, Teba ^a   Scheffers, Ingrid ^a   De Leeuw, Peter W ^a   Winkens, Bjorn ^b   Jongen Vancraybex, Heidi ^a   Tordoir, Jan H M ^a   Schmidli, Jürg ^c   Mohaupt, Markus G ^d   Allemann, Yves ^e   Kroon, Abraham A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Division of Hypertension   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

acute; carotid baroreflex activation; resistant hypertension; voltage dependent

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CAROTID SINUS PRESSORECEPTOR REFLEX; CAROTID SINUS PRESSORECEPTOR REFLEX STIMULATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIURETIC THERAPY; ELECTRIC POTENTIAL; ELECTROSTIMULATION; FEMALE; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; IMPLANT; IMPLANTATION; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEOS IMPLANT; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT DURATION; VOLTAGE RESPONSE TEST;

EID: 84863849300     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283551f10     Document Type: Article

References (36)

1. Schwartz SI, Griffith LS, Neistadt A, Hagfors N. Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. Am J Surg 1967; 114:5-15.
2. Scheffers I, Kroon A, Schmidli J, Jordan J, Tordoir J, Mohaupt M, et al. Novel carotid baroreflex activation therapy in resistant hypertension: results of a European multicenter feasibility and proof-of-principle study. J Am Coll Cardiol 2010; 56:1254-1258.
3. Tordoir JH, Scheffers I, Schmidli J, Savolainen H, Liebeskind U, Hansky B, et al. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multicenter feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg 2007; 33:414-421.
4. Schmidli J, Savolainen H, Eckstein F, Irwin E, Peters TK, Martin R, et al. Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular 2007; 15:63-69.
5. National Institutes of Health. Device Based Therapy in Hypertension Trial (DEBuT-HT). Available at: http://clinicaltrialgov [identifier NCT0071029].
6. Bevegard BS, Shepherd JT. Circulatory effects of stimulating the carotid arterial stretch receptors in man at rest and during exercise. J Clin Investig 1966; 45:132-142.
7. Goldstein DS. Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation 1983; 68:234-240.
8. Eckberg DL. Carotid baroreflex function in young men with borderline blood pressure elevation. Circulation 1979; 59:632-636.
9. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. New York: John Wiley and Sons; 2004.
10. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics 1982; 38:963-974.
11. Carlini R, Obialo CI, Rothstein M. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients. Am J Hypertens 1993; 6:103-107.
12. Gorman PH, Mortimer JT. The effect of stimulus parameters on the recruitment characteristics of direct nerve stimulation. IEEE Trans Biomed Eng 1983; 30:407-414.
13. Pilowsky PM, Goodchild AK. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 2002; 20:1675-1688.
14. Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 2004; 43:306-311.
15. Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, et al. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension 2009; 54:530-536.
16. Guyton AC, Coleman TG, Fourcade JC, Navar LG. Physiologic control of arterial pressure. Bull N Y Acad Med 1969; 45:811-830.
17. McCubbin JW, Green JH, Page IH. Baroceptor function in chronic renal hypertension. Circ Res 1956; 4:205-210.
18. Krieger EM. Arterial baroreceptor resetting in hypertension (the J.W. McCubbin memorial lecture). Clin Exp Pharmacol Physiol Suppl 1989; 15:3-17.
19. Cowley AW Jr, Liard JF, Guyton AC. Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res 1973; 32:564-576.
20. Guyton AC. Blood pressure control: special role of the kidneys and body fluids. Science 1991; 252:1813-1816.
21. Sleight P. The importance of the autonomic nervous system in health and disease. Aust N Z J Med 1997; 27:467-473.
22. Persson PB, Ehmke H, Kirchheim HR. Blood pressure control in arterial-and cardiopulmonary receptor denervated dogs. Acta Physiol Scand 1991; 142:221-228.
23. Sleight P, Robinson JL, Brooks DE, Rees PM. Characteristics of single carotid sinus baroreceptor fibers and whole nerve activity in the normotensive and the renal hypertensive dog. Circ Res 1977; 41:750-758.
24. Heusser K, Tank J, Engeli S, Diedrich A, Eckert JMS, Peters T, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010; 55:619-626.
25. Brest AN, Wiener L, Bachrach B. Bilateral carotid sinus nerve stimulation in the treatment of hypertension. Am J Cardiol 1972; 29:821-825.
26. Coleridge HM, Coleridge JC, Schultz HD. Characteristics of C fibre baroreceptors in the carotid sinus of dogs. J Physiol 1987; 394:291-313.
27. Schwartz S. Clinical applications of carotid sinus nerve stimulation. Cardiovasc Clin 1969; 1:208-222.
28. Tuckman J, Reich T, Lyon A. Electrical stimulation of the sinus nerves in hypertensive patients. Hypertension New York: American Heart Association; 1968. pp. 23-38.
29. Thrasher TN. Baroreceptors, baroreceptor unloading, and the longterm control of blood pressure. Am J Physiol Regul Integr Comp Physiol 2005; 288:R819-R827.
30. Chapleau MW, Hajduczok G, Abboud FM. Peripheral and central mechanisms of baroreflex resetting. Clin Exp Pharmacol Physiol Suppl 1989; 15:31-43.
31. Smith ML, Fritsch JM, Eckberg DL. Rapid adaptation of vagal baroreflexes in humans. J Auton Nerv Syst 1994; 47:75-82.
32. Munch PA, Andresen MC, Brown AM. Rapid resetting of aortic baroreceptors in vitro. Am J Physiol 1983; 244:H672-H680.
33. Heesch CM, Thames MD, Abboud FM. Acute resetting of carotid sinus baroreceptors. I. Dissociation between discharge and wall changes. Am J Physiol 1984; 247:H824-H832.
34. Kougias P, Weakley SM, Yao Q, Lin PH, Chen C. Arterial baroreceptors in the management of systemic hypertension. Med Sci Monit 2010; 16:RA1-RA8.
35. Kirchheim HR. Systemic arterial baroreceptor reflexes. Physiol Rev 1976; 56:100-177.
36. Andresen MC, Yang M. Arterial baroreceptor resetting: contributions of chronic and acute processes. Clin Exp Pharmacol Physiol Suppl 1989; 15:19-30.